V. Golfinopoulos

576 total citations
10 papers, 182 citations indexed

About

V. Golfinopoulos is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, V. Golfinopoulos has authored 10 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in V. Golfinopoulos's work include Glioma Diagnosis and Treatment (5 papers), Brain Metastases and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). V. Golfinopoulos is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Brain Metastases and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). V. Golfinopoulos collaborates with scholars based in Belgium, Netherlands and France. V. Golfinopoulos's co-authors include Martin J. van den Bent, Thierry Gorlia, Roger Stupp, Michael Weller, Martine Piccart, Bruno Vanderlinden, Lieveke Ameye, Wolfgang Wick, Patrick Emonts and C. Garcia and has published in prestigious journals such as Scientific Reports, Annals of Oncology and Seminars in Cancer Biology.

In The Last Decade

V. Golfinopoulos

9 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Golfinopoulos Belgium 5 110 69 64 54 32 10 182
Angelo Dipasquale Italy 9 80 0.7× 36 0.5× 19 0.3× 66 1.2× 46 1.4× 23 217
Stefanie Brehmer Germany 9 177 1.6× 132 1.9× 60 0.9× 25 0.5× 17 0.5× 25 239
Caroline Domerg United States 4 62 0.6× 71 1.0× 13 0.2× 66 1.2× 33 1.0× 5 191
Nicolas Whenham Belgium 7 42 0.4× 64 0.9× 29 0.5× 82 1.5× 26 0.8× 17 234
Daniel A. Wattson United States 5 34 0.3× 53 0.8× 17 0.3× 60 1.1× 31 1.0× 6 205
Thomas Spanberger Austria 3 133 1.2× 246 3.6× 56 0.9× 193 3.6× 14 0.4× 7 323
Michele Ly United States 6 38 0.3× 44 0.6× 12 0.2× 50 0.9× 42 1.3× 16 166
Jochen Tüttenberg Germany 7 95 0.9× 27 0.4× 86 1.3× 31 0.6× 17 0.5× 9 187
Evgeny Sadikov Canada 8 42 0.4× 93 1.3× 15 0.2× 95 1.8× 40 1.3× 16 180
Bryn Pressnail Canada 4 64 0.6× 65 0.9× 27 0.4× 59 1.1× 25 0.8× 6 165

Countries citing papers authored by V. Golfinopoulos

Since Specialization
Citations

This map shows the geographic impact of V. Golfinopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Golfinopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Golfinopoulos more than expected).

Fields of papers citing papers by V. Golfinopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Golfinopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Golfinopoulos. The network helps show where V. Golfinopoulos may publish in the future.

Co-authorship network of co-authors of V. Golfinopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of V. Golfinopoulos. A scholar is included among the top collaborators of V. Golfinopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Golfinopoulos. V. Golfinopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Morfouace, Marie, Silvia Novello, Christophe Dooms, et al.. (2022). Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform. Scientific Reports. 12(1). 8342–8342. 1 indexed citations
2.
Klein, Martin, Martin J. van den Bent, Jacoline E. C. Bromberg, et al.. (2020). Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033. Neuro-Oncology. 23(5). 803–811. 29 indexed citations
3.
Bent, Martin J. van den, Sara Erridge, Michael A. Vogelbaum, et al.. (2019). PL3.3 Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion. Neuro-Oncology. 21(Supplement_3). iii3–iii3. 18 indexed citations
4.
Preusser, Matthias, Antonio Silvani, Émilie Le Rhun, et al.. (2019). PL3.2 Trabectedin for recurrent WHO grade II or III meningioma: a randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG). Neuro-Oncology. 21(Supplement_3). iii2–iii3. 5 indexed citations
5.
Morfouace, Marie, Stephen M. Hewitt, Roberto Salgado, et al.. (2018). A transatlantic perspective on the integration of immuno-oncology prognostic and predictive biomarkers in innovative clinical trial design. Seminars in Cancer Biology. 52(Pt 2). 158–165. 2 indexed citations
7.
Folprecht, Gunnar, Philip Beer, Ramón Salazar, et al.. (2016). Frequency of potentially actionable genetic alterations in EORTC SPECTAcolor. Annals of Oncology. 27. vi151–vi151. 1 indexed citations
8.
Idbaïh, Ahmed, Paul M. Clément, Filip De Vos, et al.. (2016). OS5.7 First results of the randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact 1st recurrence grade II and III glioma. Neuro-Oncology. 18(suppl_4). iv13–iv13. 1 indexed citations
9.
Wick, Wolfgang, Thierry Gorlia, Martin Bendszus, et al.. (2015). LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL. Neuro-Oncology. 17(suppl 5). v1.5–v1. 62 indexed citations
10.
Hendlisz, Alain, V. Golfinopoulos, C. Garcia, et al.. (2011). Serial FDG–PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy. Annals of Oncology. 23(7). 1687–1693. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026